Emergent BioSolutions (EBS) Goodwill (2010 - 2023)

Emergent BioSolutions' Goodwill history runs 14 years deep, the most recent figure standing at $218.2 million for Q2 2023.

• On a quarterly basis, Goodwill fell 2.98% year-over-year to $218.2 million in Q2 2023; TTM through Jun 2023 was $218.2 million, a 2.98% decrease from a year earlier, with the FY2022 full-year figure at $218.2 million, down 2.98% from the prior year.
• Goodwill was little changed at $218.2 million in Q2 2023 per EBS's latest filing, from $218.2 million in the prior quarter.
• Across five years, Goodwill topped out at $268.6 million in Q3 2019 and bottomed at $218.2 million in Q4 2022.
• The 5-year median for Goodwill is $266.4 million (2020), against an average of $249.5 million.
• Across the five-year window, Goodwill soared 446.71% in 2019 and fell 15.67% in 2021, its largest moves.
• Year by year, Goodwill stood at $266.6 million in 2019, then gained by 0.04% to $266.7 million in 2020, then decreased by 15.67% to $224.9 million in 2021, then retreated by 2.98% to $218.2 million in 2022, then changed by 0.0% to $218.2 million in 2023.
• Per Business Quant, the three latest EBS Goodwill figures stand at $218.2 million (Q2 2023), $218.2 million (Q1 2023), and $218.2 million (Q4 2022).